Literature DB >> 9828766

Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis.

E H Bosch-Driessen1, A Rothova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9828766      PMCID： PMC1722725          DOI： 10.1136/bjo.82.8.858

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  16 in total

1.  Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

Authors:  Sibylle Winterhalter; Katja Severing; Johannes Stammen; Anna Karina Maier; Erhard Godehardt; Antonia Maria Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

2.  An ophthalmologist survey-based study of the atypical presentations and current treatment practices of ocular toxoplasmosis in India.

Authors:  Soumyava Basu; Jyotirmay Biswas; Uwe Pleyer; Avinash Pathangay; B Manohar Babu
Journal:  J Parasit Dis       Date:  2011-05-07

3.  Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.

Authors:  Dorte Remmer Schmidt; Birthe Hogh; Ole Andersen; Steen Honoré Hansen; Kim Dalhoff; Eskild Petersen
Journal:  Eur J Pediatr       Date:  2005-08-20       Impact factor: 3.183

Review 4.  Ocular toxoplasmosis II: clinical features, pathology and management.

Authors:  Nicholas J Butler; João M Furtado; Kevin L Winthrop; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2012-09-17       Impact factor: 4.207

Review 5.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

6.  The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.

Authors:  D R Schmidt; B Hogh; O Andersen; J Fuchs; H Fledelius; E Petersen
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

7.  [Diagnosis and treatment of ocular toxoplasmosis : a survey of German-speaking ophthalmologists].

Authors:  N Torun; Z Sherif; J Garweg; U Pleyer
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

Review 8.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

9.  The absence of vitreous inflammation: one more challenge in diagnosing toxoplasma papillitis.

Authors:  Michael Adly Mikhail; Mohan Varikkara
Journal:  BMJ Case Rep       Date:  2013-04-09

Review 10.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.